Prostate cancer 2012: where do we stand and where are we heading?

Oncology (Williston Park). 2012 Dec;26(12):1222, 1224.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Bone Neoplasms / therapy*
  • Humans
  • Male
  • Prostatic Neoplasms / therapy*
  • Radiopharmaceuticals / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Radiopharmaceuticals